23 related articles for article (PubMed ID: 12842705)
1. Discovery of a selective TC-PTP degrader for cancer immunotherapy.
Miao J; Dong J; Miao Y; Bai Y; Qu Z; Jassim BA; Huang B; Nguyen Q; Ma Y; Murray AA; Li J; Low PS; Zhang ZY
Chem Sci; 2023 Nov; 14(44):12606-12614. PubMed ID: 38020389
[TBL] [Abstract][Full Text] [Related]
2. Current Views on the Interplay between Tyrosine Kinases and Phosphatases in Chronic Myeloid Leukemia.
Boni C; Sorio C
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065882
[TBL] [Abstract][Full Text] [Related]
3. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.
Bachmann SB; Frommel SC; Camicia R; Winkler HC; Santoro R; Hassa PO
Mol Cancer; 2014 May; 13():125. PubMed ID: 24886089
[TBL] [Abstract][Full Text] [Related]
4. Protein tyrosine phosphatases PTP-1B and TC-PTP play nonredundant roles in macrophage development and IFN-gamma signaling.
Heinonen KM; Bourdeau A; Doody KM; Tremblay ML
Proc Natl Acad Sci U S A; 2009 Jun; 106(23):9368-72. PubMed ID: 19474293
[TBL] [Abstract][Full Text] [Related]
5. Protein tyrosine phosphatase 1B negatively regulates macrophage development through CSF-1 signaling.
Heinonen KM; Dubé N; Bourdeau A; Lapp WS; Tremblay ML
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2776-81. PubMed ID: 16477024
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane signaling by IFN-alpha.
Pfeffer LM; Constantinescu SN; Wang C
Prog Mol Subcell Biol; 1994; 14():242-59. PubMed ID: 7520330
[No Abstract] [Full Text] [Related]
7. A novel mechanism for imatinib mesylate (STI571) resistance in CML cell line KT-1: role of TC-PTP in modulating signals downstream from the BCR-ABL fusion protein.
Shimizu T; Miyakawa Y; Iwata S; Kuribara A; Tiganis T; Morimoto C; Ikeda Y; Kizaki M
Exp Hematol; 2004 Nov; 32(11):1057-63. PubMed ID: 15539083
[TBL] [Abstract][Full Text] [Related]
8. The role of TC-PTP (PTPN2) in modulating sensitivity to imatinib and interferon-α in CML cell line, KT-1 cells.
Nishiyama-Fujita Y; Shimizu T; Sagawa M; Uchida H; Kizaki M
Leuk Res; 2013 Sep; 37(9):1150-5. PubMed ID: 23759247
[TBL] [Abstract][Full Text] [Related]
9. Identification of a nuclear Stat1 protein tyrosine phosphatase.
ten Hoeve J; de Jesus Ibarra-Sanchez M; Fu Y; Zhu W; Tremblay M; David M; Shuai K
Mol Cell Biol; 2002 Aug; 22(16):5662-8. PubMed ID: 12138178
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
11. Development of interferon-alpha resistant subline from human chronic myelogenous leukemia cell line KT-1.
Yamauchi H; Sakai I; Narumi H; Takeuchi K; Soga S; Fujita S
Intern Med; 2001 Jul; 40(7):607-12. PubMed ID: 11506301
[TBL] [Abstract][Full Text] [Related]
12. STI571-resistant KT-1 cells are sensitive to interferon-alpha accompanied by the loss of T-cell protein tyrosine phosphatase and prolonged phosphorylation of Stat1.
Shimizu T; Miyakawa Y; Oda A; Kizaki M; Ikeda Y
Exp Hematol; 2003 Jul; 31(7):601-8. PubMed ID: 12842705
[TBL] [Abstract][Full Text] [Related]
13. [Tyrosine kinase inhibitor as a therapeutic drug for chronic myelogenous leukemia and gastrointestinal stromal tumor].
Nakajima M; Toga W
Nihon Yakurigaku Zasshi; 2003 Dec; 122(6):482-90. PubMed ID: 14639002
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
